RU2019130955A3 - - Google Patents

Download PDF

Info

Publication number
RU2019130955A3
RU2019130955A3 RU2019130955A RU2019130955A RU2019130955A3 RU 2019130955 A3 RU2019130955 A3 RU 2019130955A3 RU 2019130955 A RU2019130955 A RU 2019130955A RU 2019130955 A RU2019130955 A RU 2019130955A RU 2019130955 A3 RU2019130955 A3 RU 2019130955A3
Authority
RU
Russia
Application number
RU2019130955A
Other languages
Russian (ru)
Other versions
RU2019130955A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2019130955A publication Critical patent/RU2019130955A/ru
Publication of RU2019130955A3 publication Critical patent/RU2019130955A3/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/04Artificial tears; Irrigation solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
RU2019130955A 2017-03-05 2018-02-19 Глазные капли для лечения раздражения, не вызванного инфекцией RU2019130955A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762467139P 2017-03-05 2017-03-05
US62/467,139 2017-03-05
PCT/IL2018/050184 WO2018163151A1 (en) 2017-03-05 2018-02-19 Eye drops for treatment of irritation not due to infection

Publications (2)

Publication Number Publication Date
RU2019130955A RU2019130955A (ru) 2021-04-07
RU2019130955A3 true RU2019130955A3 (enExample) 2021-06-24

Family

ID=61656085

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2019130955A RU2019130955A (ru) 2017-03-05 2018-02-19 Глазные капли для лечения раздражения, не вызванного инфекцией

Country Status (14)

Country Link
US (2) US11033513B2 (enExample)
EP (2) EP3592339B1 (enExample)
JP (1) JP7258778B2 (enExample)
KR (1) KR102652879B1 (enExample)
CN (1) CN110891555B (enExample)
AU (1) AU2018230262B2 (enExample)
BR (1) BR112019018367A2 (enExample)
CA (1) CA3055523C (enExample)
ES (1) ES3036888T3 (enExample)
IL (1) IL269133B2 (enExample)
MX (1) MX388961B (enExample)
PL (1) PL3592339T3 (enExample)
RU (1) RU2019130955A (enExample)
WO (1) WO2018163151A1 (enExample)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL80298A (en) 1986-10-14 1993-01-31 Res & Dev Co Ltd Eye drops
US5895645A (en) * 1995-01-31 1999-04-20 Bausch & Lomb Incorporated Opthalmic solution for artificial tears
JP3093661B2 (ja) * 1995-10-12 2000-10-03 大塚製薬株式会社 眼疾患治療剤
AR004214A1 (es) * 1995-10-12 1998-11-04 Otsuka Pharma Co Ltd Una preparación de gotas oftálmicas para la cura de enfermedades oftálmicas
IL120005A (en) * 1997-01-14 2000-08-31 Ramot University Authority Of Pharmaceutical compositions for the treatment of the eye
US5800807A (en) * 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol
IL168603A (en) * 2005-05-16 2011-05-31 Resdevco Res And Dev Co Pharmaceutical or cosmetic composition for the prevention and treatment of irritation of mucous cells or skin cells
DE102005055275A1 (de) 2005-11-17 2007-05-24 Ursapharm Arzneimittel Gmbh & Co. Kg Phosphatfreie pharmazeutische Zusammensetzung sowie deren Verwendung
IL212725A (en) * 2011-05-05 2016-06-30 Resdevco Res And Dev Co Glycerol Preparation for Non-surgical Conjunctivochalysis
KR102107471B1 (ko) 2011-11-24 2020-05-07 토요 슈가 리파이닝 컴퍼니 리미티드 각결막 보호제 또는 각결막 장해 억제제
US9278132B2 (en) 2012-02-13 2016-03-08 Bausch & Lomb Incorporated Ophthalmic pharmaceutical compositions and methods of making and using same

Also Published As

Publication number Publication date
CA3055523A1 (en) 2018-09-13
EP4385565A2 (en) 2024-06-19
KR20190129065A (ko) 2019-11-19
EP3592339A1 (en) 2020-01-15
JP7258778B2 (ja) 2023-04-17
US20190388361A1 (en) 2019-12-26
CN110891555A (zh) 2020-03-17
US11426361B2 (en) 2022-08-30
KR102652879B1 (ko) 2024-03-29
AU2018230262B2 (en) 2024-01-18
CA3055523C (en) 2024-10-01
EP3592339C0 (en) 2025-04-30
IL269133B1 (en) 2024-05-01
MX388961B (es) 2025-03-20
EP3592339B1 (en) 2025-04-30
EP4385565A3 (en) 2024-08-21
US20210186892A1 (en) 2021-06-24
AU2018230262A1 (en) 2019-09-26
WO2018163151A1 (en) 2018-09-13
PL3592339T3 (pl) 2025-09-01
BR112019018367A2 (pt) 2020-04-07
US11033513B2 (en) 2021-06-15
RU2019130955A (ru) 2021-04-07
CN110891555B (zh) 2023-12-26
JP2020509092A (ja) 2020-03-26
MX2019010471A (es) 2020-02-12
IL269133A (en) 2019-11-28
IL269133B2 (en) 2024-09-01
ES3036888T3 (en) 2025-09-25

Similar Documents

Publication Publication Date Title
BR122021024397A2 (enExample)
BR122021000189A2 (enExample)
BR112020006084A8 (enExample)
BR122022025811B8 (enExample)
BR202018014992U2 (enExample)
BR122021023687A2 (enExample)
BR122021014832A2 (enExample)
BR122022003518A2 (enExample)
RU2019130955A3 (enExample)
BR112020008820A2 (enExample)
BR202017025154U2 (enExample)
BR202017021228U2 (enExample)
BR202017020981U2 (enExample)
BR202017017068U2 (enExample)
BR202017016984U2 (enExample)
BR202017016924U2 (enExample)
BR202017012548U2 (enExample)
BR202017011220U2 (enExample)
BR202017010814U2 (enExample)
BR202017010373U2 (enExample)
BR202017009870U2 (enExample)
BR202017006953U2 (enExample)
BR202017004898U2 (enExample)
BR202017002937U2 (enExample)
BR202017002826U2 (enExample)